| 259.96 |  -3.68 / -1.40% |
Data as of 4:00pm ET | Day’s Change |
| 261.88 |  +1.92 / +0.74% |
Volume: 7,000.00 |
| 5 Stocks Underperforming Today In The Drugs Industry May 20 / TheStreet.com | Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Drugs Laggard May 15 / TheStreet.com |
| Regeneron Pharmaceuticals Inc. Stock Buy Recommendation Reiterated (REGN) May 20 / TheStreet.com | 3 Stocks Underperforming Today In The Drugs Industry May 15 / TheStreet.com |
| Sanofi/REGN Commence Enrollment - Analyst Blog May 15 / Zacks.com |
| Previous close | 263.64 |
| Today’s open | 264.39 |
| Day’s range | 255.09 - 266.05 |
| Volume | 804,876 |
| Average volume (3 months) | 1,109,960 |
| Market cap | $25.8B |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -41.06% |
| Earnings growth (next 5 years) | +34.36% |
| Revenue growth (last year) | +209.20% |
| P/E ratio | 34.6 |
| Price/Sales | 11.75 |
| Price/Book | 20.60 |
| Today’s change | Today’s % change | |
|---|---|---|
| CBSTCubist Pharmaceutica... | +1.98 | +3.70% |
| ARIAARIAD Pharmaceutical... | +0.91 | +5.48% |
| PRXLPAREXEL Internationa... | -0.20 | -0.43% |
| ISISIsis Pharmaceuticals... | +0.35 | +1.71% |
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | $0.85 |
| Annual revenue (last year) | $1.4B |
| Annual profit (last year) | $750.3M |
| Net profit margin | 54.43% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Leonard S. Schleifer, MD, PhD |
Chief Financial Officer & Senior VP-Administration Murray A. Goldberg, MBA |
Corporate headquarters Tarrytown, New York |
.
